Competing in the US Molecular Diagnostics Market

Competing in the US Molecular Diagnostics Market

Category : Diagnostic and Biotech
February  2013 

------------ Or -------------

This new 880-page report from Venture Planning Group contains 37 tables, and presents a comprehensive analysis of the US molecular diagnostics market, including:

  • Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Five-year test volume and reagent sales forecasts for the following categories:

   -  Infectious Diseases                  -  Genetic Diseases 
   -  Cancer                                      -  Paternity Testing/HLA Typing 
   -  Forensic Testing 

  • Review of testing methodologies an instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.

Contains 880 pages and 37 tables

Enquiry Before Buy